These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38754214)

  • 1. Five-layer-funnel filtering mode discovers effective components of Chinese medicine formulas: Zhishi-Xiebai-Guizhi decoction as a case study.
    Wang Q; Wang Q; Huang Q; Zhang X; Qin Z; Yu Y; Dai Y; Han J; Yao X; He L; Lin P; Yao Z
    Phytomedicine; 2024 Jul; 129():155678. PubMed ID: 38754214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network Pharmacology Study on Molecular Mechanisms of Zhishi Xiebai Guizhi Decoction in the Treatment of Coronary Heart Disease.
    Gao J; Pan Y; Zhao Y; Li H; Mi Z; Chen H; Tan X
    Evid Based Complement Alternat Med; 2021; 2021():3574321. PubMed ID: 34966435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a three-step-based novel strategy integrating DMPK with network pharmacology and bioactivity evaluation for the discovery of Q-markers of traditional Chinese medicine prescriptions: Danlou tablet as an example.
    Wang Q; Chen G; Chen X; Liu Y; Qin Z; Lin P; Shang H; Ye M; He L; Yao Z
    Phytomedicine; 2023 Jan; 108():154511. PubMed ID: 36334388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical profiling and quality evaluation of Zhishi-Xiebai-Guizhi Decoction by UPLC-Q-TOF-MS and UPLC fingerprint.
    Sang Q; Jia Q; Zhang H; Lin C; Zhao X; Zhang M; Wang Y; Hu P
    J Pharm Biomed Anal; 2021 Feb; 194():113771. PubMed ID: 33280997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Coronary heart disease: innovative understanding from traditional Chinese medicine and treatment by classic formulas].
    Lan Y; Luo FK; Yu Y; Wang XY; Wang PQ; Xiong XJ
    Zhongguo Zhong Yao Za Zhi; 2024 Jul; 49(13):3684-3692. PubMed ID: 39041141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on the Active Constituents and Molecular Mechanism of Zhishi Xiebai Guizhi Decoction in the Treatment of CHD Based on UPLC-UESI-Q Exactive Focus, Gene Expression Profiling, Network Pharmacology, and Experimental Validation.
    Liu Y; He X; Di Z; Du X
    ACS Omega; 2022 Feb; 7(5):3925-3939. PubMed ID: 35155889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative pharmacogenomic analysis of three classic TCM prescriptions for coronary heart disease based on molecular network modeling.
    Zhang YY; Zhao ZD; Kong PY; Gao L; Yu YN; Liu J; Wang PQ; Li B; Zhang XX; Yang LQ; Wang Z
    Acta Pharmacol Sin; 2020 Jun; 41(6):735-744. PubMed ID: 32051552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of the toxicity-related quality markers and mechanisms of Zhi-Zi-Hou-Po decoction based on Chinmedomics combined with differentially absorbed components and network pharmacology.
    Wan S; Xie X; Yang G; Feng F
    J Ethnopharmacol; 2024 Feb; 320():117408. PubMed ID: 37972910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic profile and potential mechanisms of Wendan decoction on coronary heart disease by ultra-high-performance quadrupole time of flight-mass spectrometry combined with network pharmacology analysis.
    Wang Q; Chen J; Zhang Y; Xu D; Wu H; Lin P; He L; Qin Z; Yao Z
    J Sep Sci; 2023 Jan; 46(1):e2200456. PubMed ID: 36300722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualitative and quantitative analysis of the chemical profile for Gualou-Xiebai-Banxia decoction, a classical traditional Chinese medicine formula for the treatment of coronary heart disease, by UPLC-Q/TOF-MS combined with chemometric analysis.
    Lin P; Wang Q; Liu Y; Jiang H; Lv W; Lan T; Qin Z; Yao X; Yao Z
    J Pharm Biomed Anal; 2021 Apr; 197():113950. PubMed ID: 33609948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Mechanism of Zhishi-Xiebai-Guizhi Decoction for the Treatment of Hypoxic Pulmonary Hypertension based on Network Pharmacology and Experimental Analyses.
    Huang P; Wang Y; Liu C; Zhang Q; Ma Y; Liu H; Wang X; Wang Y; Wei M; Ma L
    Curr Pharm Des; 2024; 30(26):2059-2074. PubMed ID: 38867532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on the mechanism of Gualou Xiebai Guizhi decoction (GLXBGZD) in the treatment of coronary heart disease based on network pharmacology.
    Teng C; Wang Y; Pang S; Wei X; Liu X
    Medicine (Baltimore); 2022 Jul; 101(29):e29490. PubMed ID: 35866783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Traditional Chinese Medicine combined with Western Medicine on blood lipid levels and inflammatory factors in patients with angina pectoris in coronary heart disease identified as intermingled phlegm and blood stasis syndrome: a network Meta-analysis.
    Chao W; Qiong WU; Ping LI; Zhigang W; Xusheng L; Yuanyuan LI; Lin Z
    J Tradit Chin Med; 2023 Aug; 43(4):640-649. PubMed ID: 37454248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical profile and potential mechanisms of Huo-Tan-Chu-Shi decoction in the treatment of coronary heart disease by UHPLC-Q/TOF-MS in combination with network pharmacology analysis and experimental verification.
    He L; Jiang H; Lan T; Qiu Y; Yang K; Chen K; Yao X; Yao Z; Lu W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1175():122729. PubMed ID: 33992976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics integrated with network pharmacology to clarify effective components and mechanism of Wendan decoction for the intervention of coronary heart disease.
    Lin P; Hu L; Huang Q; Zhang Y; Qin Z; Chen J; Yao X; Wu H; Yao Z; Xu D
    J Ethnopharmacol; 2023 Oct; 314():116669. PubMed ID: 37217155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of Zhishi Xiebai Guizhi decoction to treat atherosclerosis: Insights into experiments, network pharmacology and molecular docking.
    Zhang Z; Gao J; Wang J; Mi Z; Li H; Dai Z; Pan Y; Dong J; Chen S; Lu S; Tan X; Chen H
    J Ethnopharmacol; 2024 Oct; 333():118466. PubMed ID: 38885915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A stepwise integrated multi-system to screen quality markers of Chinese classic prescription Qingzao Jiufei decoction on the treatment of acute lung injury by combining 'network pharmacology-metabolomics-PK/PD modeling'.
    Wang T; Lin S; Li H; Liu R; Liu Z; Xu H; Li Q; Bi K
    Phytomedicine; 2020 Nov; 78():153313. PubMed ID: 32866904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The discovery of Q-markers of Qiliqiangxin Capsule, a traditional Chinese medicine prescription in the treatment of chronic heart failure, based on a novel strategy of multi-dimensional "radar chart" mode evaluation.
    He L; Liu Y; Yang K; Zou Z; Fan C; Yao Z; Dai Y; Li K; Chen J; Yao X
    Phytomedicine; 2021 Feb; 82():153443. PubMed ID: 33429210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zhishi Xiebai Guizhi Decoction for coronary heart disease: A systematic review and meta-analysis.
    Li M; Song S; Rong Y; Wu D; Yin Y
    Medicine (Baltimore); 2024 Jan; 103(3):e36588. PubMed ID: 38241594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of the mechanisms and major bioactive compounds responsible for the protective effects of Gualou Xiebai Decoction on coronary heart disease by network pharmacology analysis.
    Li C; Zhang WY; Yu Y; Cheng CS; Han JY; Yao XS; Zhou H
    Phytomedicine; 2019 Mar; 56():261-268. PubMed ID: 30668346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.